We scan new podcasts and send you the top 5 insights daily.
Restoring physical movement after spinal injury does not require repairing damaged nerve tissue directly. Dr. MacDougall notes that researchers can route intact motor cortex commands directly to a secondary implant located in the spinal cord below the lesion, utilizing the remaining intact motor wiring.
Dr. MacDougall explains that neural implant electrodes have micron-width loops that must navigate dense brain surface blood vessels blindly. Human surgeons lack the motor skills and steadiness to insert these threads through cortical layers safely, requiring automated robotic systems.
Brain interfaces do not initially comprehend the user's motor intention signals upon implantation. Instead, software algorithms identify firing patterns during guided tasks while the human brain simultaneously learns the system's software model, creating a co-adaptive feedback loop that stabilizes daily cursor control.
In its spinal cord injury trial, NervGen's NVG-291 demonstrated that patients' hand function continued to improve even four weeks after they stopped the daily drug administration. This provides strong evidence that the therapy is creating permanent new neuronal connections, rather than offering only a temporary effect.
Contrary to the long-held belief that nerves don't regrow, scientists have achieved 100% regeneration of crushed optic nerves in mice, restoring their sight. This groundbreaking success, far surpassing previous 5% regrowth rates, opens the door to treating spinal cord injuries and neurodegenerative diseases like ALS.
While companies like Neuralink popularize assistive BCIs for controlling external devices, a different segment is focused on therapeutic applications. Companies like InBrain aim not to control computers but to use high-resolution interfaces to directly heal or modulate neural circuits for treating diseases.
Neuralink's immediate clinical objective focuses on enabling quadriplegic individuals to control external computers rather than re-animating paralyzed limbs. Because motor cortex signals remain pristine after spinal injuries, decoding intentional cortical activity allows direct manipulation of keyboards, mice, and digital tools.
Contrary to the belief that recovery is limited to the months post-injury, NervGen's trial specifically enrolled and showed significant functional improvement in patients with chronic injuries, some a decade old. This opens a new treatment window for a large, previously overlooked patient population.
While outsiders assume walking is the ultimate recovery goal, NervGen's research reveals that regaining hand function for daily tasks like eating or using a computer is the most vital improvement for patient independence. This highlights the importance of patient-defined quality-of-life endpoints in clinical trials.
Unlike conventional deep brain stimulation that delivers a constant current, adaptive DBS uses a bidirectional system. It senses neural activity, compares it to a threshold, and adjusts the stimulation up or down accordingly, creating a personalized therapy that responds to the patient's real-time brain state.
The science to regrow nerves and potentially treat paralysis may already be here. The primary barrier to human application is no longer the technology itself, but the immense challenge of navigating safety regulations and securing the hundreds of millions in funding required for clinical trials.